Company / Book Value per Share
Immunovant, Inc. Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.076
FY2024
5-year range
$1.072 / $4.076
FY2020-FY2024
Trend
+55.3%
vs FY2023
Sector context
#122 of 211
Health Care
What the data says
At $4.076, Immunovant, Inc.'s book value per share ranks #122 of 211 in the Health Care sector. Improved from $3.817 to $4.076 over the past 2 years.
Based on SEC 10-K filings.
$4.076 in FY2024 with a 5-year CAGR of +88.8%.
Improved from $3.817 to $4.076 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +88.8%
- 10-Year CAGR
- -
Sector benchmark
#122 of 211 in Health CareTop 58% of 211This company $4.076 Sector average $213.854
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +88.8%, indicating consistent growth.
- In FY2024, book value per share increased 55.3% year-over-year.
- Ranks #122 out of 211 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.076 | +55.3% |
| FY2023 | $2.625 | -31.2% |
| FY2022 | $3.817 | +6.9% |
| FY2021 | $3.569 | +233.0% |
| FY2020 | $1.072 | +531.0% |
| FY2019 | $0.17 | +351.6% |
| FY2018 | -$0.068 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026